This article has been updated to include the product name for Illumina's genotyping platform.
NEW YORK, Jan. 31 (GenomeWeb News) - DNAPrint Genomics said today that it has expanded the capacity for its genotyping services offering from 1.3 million genotypes per day to more than 3.9 million genotypes per day.
The company has genotyping facilities at headquarters in
DNAPrint did not provide details on the additional capacity that it has added for these platforms. Company officials could not be reached for comment.
The company said that the increase in processing capacity will enable it "to process clinical trials samples to ensure that patient population groups are accurately categorized, and perform large-scale genotyping work for the various industries interested."